Clinical Registry for the Characterization of the 'Pulmonary Vascular Phenotype' in Patients With Chronic Obstructive Pulmonary Disease

Medical University of Graz1,000 enrolled

Overview

Registry of COPD (Chronic Obstructive Pulmonary Disease) patients who underwent right heart catheterization (RHC) and full clinical evaluation for pulmonary hypertension

Study Type

OBSERVATIONAL

Enrollment

1,000

Conditions

Chronic Obstructive Pulmonary Disease (COPD)Pulmonary Hypertension

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * clinical diagnosis of COPD * right heart catheterization including mPAP (Mean Pulmonary Artery Pressure), PVR (Pulmonary Vascular Resistance), PAWP (Pulmonary Artery Wedge Pressure), CO (cardiac output) * age \>= 18 years Exclusion Criteria: * pediatric patients * no COPD or no RHC

Locations (3)

Medical University of Graz

Graz, Austria

RECRUITING

University of Zurich

Zurich, Switzerland

RECRUITING

University of Sheffield

Sheffield, United Kingdom

RECRUITING

Outcomes

Primary Outcomes

Severe Pulmonary Hypertension (PH)

pulmonary vascular resistance \> 5 WU (Wood Units)

Time frame: at inclusion

all-cause mortality

Time frame: Until 2026

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.